[HTML][HTML] A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer
TJ Lynch, D Fenton, V Hirsh, D Bodkin… - Journal of Thoracic …, 2009 - Elsevier
Introduction: This phase 2 study was conducted to determine the efficacy and safety of
erlotinib alone and with bortezomib in patients with non-small cell lung cancer (NSCLC) …
erlotinib alone and with bortezomib in patients with non-small cell lung cancer (NSCLC) …
A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer.
TJ Lynch, D Fenton, V Hirsh, D Bodkin… - Journal of Thoracic …, 2009 - europepmc.org
Methods Patients with histologically or cytologically confirmed relapsed or refractory stage
IIIb/IV NSCLC were randomized (1: 1; stratified by baseline histology, smoking history, sex) …
IIIb/IV NSCLC were randomized (1: 1; stratified by baseline histology, smoking history, sex) …
A Randomized Phase 2 Study of Erlotinib Alone and in Combination with Bortezomib in Previously Treated Advanced Non-small Cell Lung Cancer
TJ Lynch, D Fenton, V Hirsh, D Bodkin… - Journal of Thoracic …, 2009 - jto.org
Introduction: This phase 2 study was conducted to determine the efficacy and safety of
erlotinib alone and with bortezomib in patients with non-small cell lung cancer (NSCLC) …
erlotinib alone and with bortezomib in patients with non-small cell lung cancer (NSCLC) …
[PDF][PDF] A Randomized Phase 2 Study of Erlotinib Alone and in Combination with Bortezomib in Previously Treated Advanced Non-small Cell Lung Cancer
TJ Lynch, D Fenton, V Hirsh, D Bodkin… - Journal of Thoracic …, 2009 - core.ac.uk
Introduction: This phase 2 study was conducted to determine the efficacy and safety of
erlotinib alone and with bortezomib in patients with non-small cell lung cancer (NSCLC) …
erlotinib alone and with bortezomib in patients with non-small cell lung cancer (NSCLC) …
A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer
TJ Lynch, D Fenton, V Hirsh… - Journal of Thoracic …, 2009 - einstein.elsevierpure.com
INTRODUCTION: This phase 2 study was conducted to determine the efficacy and safety of
erlotinib alone and with bortezomib in patients with non-small cell lung cancer (NSCLC) …
erlotinib alone and with bortezomib in patients with non-small cell lung cancer (NSCLC) …
A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer
TJ Lynch, D Fenton, V Hirsh… - Journal of thoracic …, 2009 - pubmed.ncbi.nlm.nih.gov
Introduction This phase 2 study was conducted to determine the efficacy and safety of
erlotinib alone and with bortezomib in patients with non-small cell lung cancer (NSCLC) …
erlotinib alone and with bortezomib in patients with non-small cell lung cancer (NSCLC) …
[PDF][PDF] A Randomized Phase 2 Study of Erlotinib Alone and in Combination with Bortezomib in Previously Treated Advanced Non-small Cell Lung Cancer
TJ Lynch, D Fenton, V Hirsh, D Bodkin… - Journal of Thoracic …, 2009 - scholar.archive.org
Introduction: This phase 2 study was conducted to determine the efficacy and safety of
erlotinib alone and with bortezomib in patients with non-small cell lung cancer (NSCLC) …
erlotinib alone and with bortezomib in patients with non-small cell lung cancer (NSCLC) …